Dr. Levy's interest in leading edge medical technology and advancing medical care is long standing. He developed the first robotic approach to refractive eye surgery in mid 1980s and was actively involved in exploring areas of translational research including nanotechnology for ophthalmic applications. He has lead clinical advances in small incision and topical anesthetic cataract surgery at Mount Sinai Medical Center in New York City. His contributions to medical education include the training of many residents and setting the standard for minimally invasive eye surgery at three ophthalmology residency programs. Following a career in the practice of ophthalmology, Dr. Levy transitioned into life science and healthcare business development and is strongly focused on early stage companies enhancing their development from innovation to fundraising to networking. Located in Connecticut, he serves as CEO of MD Stem Cells, a leading provider of adult stem cell patient facilitation services for various diseases including those affecting the eye. He serves as Study Director for ongoing clinical studies include the Stem Cell Ophthalmology Treatment Study II (SCOTS2); the Neurologic Stem Cell Treatment study (NEST); the Stem Cell Spinal Cord Injury Exoskeleton & Virtual Reality study (SciExVR) addressing spinal cord paraplegia; and the Rejuvenation of Premature Ovarian Failure with Stem Cells (ROSE). All use bone marrow derived stem cells, are IRB approved, FDA compliant and registered with the United States NIH. Dr. Levy is also CEO of an early commercial stage neuroimaging company called Millennium Magnetic Technologies (MMT Neurotech) and has recently submitted a provisional patent on thought and memory playback. He is also President of the Acoma Group which provides business development services for biopharmaceutical, medical and healthcare companies globally. Dr. Levy is an Advisory Board member consultant with Gerson- Lehrman providing advice within the clinical and life sciences and on the board of the journal Clinical Trials in Degenerative Diseases.
Clinical Stem Cell research, ophthalmology including anterior segment, retinal disease and optic neuropathies, neurology and spinal cord injury, neuroimaging including diagnostic imaging of pain, depression, fibromyalgia, preclinical Alzheimerís disease, Autism Spectrum Disorder, thought and memory recording and playback.